- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02781350
Anti-inflammatory Effects of Fiber
May 23, 2016 updated by: Paresh Dandona, University at Buffalo
To Study the Effect of High Fat High Carbohydrate Meal on Oxidative Load, Inflammatory Mediators and Insulin Resistance in Normal and Obese Subjects
The main objective of this research is to investigate the effect of addition of fiber on the high fat high carbohydrate (HFHC) meal induced inflammation and oxidative stress mechanisms at the molecular level in humans, in vivo.
The investigators have previously shown that the intake of one HFHC meal leads to an increase in oxidative stress and inflammation.
HFHC meal also induces an increase in the expression of suppressor of cytokine signaling- 3 (SOCS-3) in the mononuclear cells (MNC), which interferes with insulin signal transduction and contributes to the pathogenesis of insulin resistance.
In contrast, an American heart association (AHA) meal rich in fruits and fiber does not induce these effects.
These observations are important since HFHC meal not only induces oxidative stress and inflammation but also lays the foundations of a potentially greater insulin resistance through the induction of SOCS-3, TLR-4 and TLR-2.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The main objective of this research is to investigate the effect of high fat high carbohydrate (HFHC) meal on inflammatory mechanisms at the molecular level in humans, in vivo versus HFHC meal plus fiber.
HFHC meal includes egg muffin, sausage muffin sandwiches and two hash browns.
The Investigators have previously shown that the intake of one HFHC meal leads to an increase in reactive oxygen species (ROS) generation and the expression of p47, the key subunit of NADPH oxidase, with a concomitant increase in intranuclear nuclear factor κB (NFkB) binding.
More recently, the investigators have also shown that HFHC meal leads to an increase in plasma endotoxin (lipopolysaccharide, LPS) concentrations along with an increase in the expression of Toll like receptor-4 (TLR-4), the receptor for endotoxin, and TLR-2, the receptor for several products of Gram positive bacteria.
In addition, it also causes an increase in lipopolysaccharide binding protein (LBP), the protein which facilitates the binding of LPS to CD14 and TLR-4.
Finally, HFHC meal also induces an increase in the expression of suppressor of cytokine signaling- 3 (SOCS-3) in the mononuclear cells (MNC) (1), which interferes with insulin signal transduction and contributes to the pathogenesis of insulin resistance.
In contrast, an AHA meal does not induce these effects.
These observations are important since HFHC meal not only induces oxidative stress and inflammation but also lays the foundations of (2) a potentially greater response to an inflammatory challenge through the induction of an increase in LPS concentrations and the expression of TLR-4 and TLR-2; and (3) insulin resistance through the induction of SOCS-3, TLR-4 and TLR-2.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14215
- ECMC Ambulatory Center, 3rd Floor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 18 to 80 years of age
- Subject will be available for duration of the study and willing to comply with all study requirements
- Written and informed consent signed and dated
- Nonsmoker
Exclusion Criteria:
- Coronary artery disease (CAD): documented by history of myocardial infarction, angioplasty/stent placement, angina, exercise EKG positive for ischemia or angiographic evidence of CAD
- Patient on non-steroidal anti-inflammatory drugs or steroids
- Hepatic disease (transaminase > 3 times normal)
- Renal impairment (serum creatinine > 1.5 mg/dl)
- History of drug or alcohol abuse
- Participation in any other concurrent clinical trials
- Use of an investigational agent or therapeutic regimen within 30 days of study
- Pregnancy
- Premenopausal women who are trying to be pregnant
- Anemia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: High fat high carbohydrate (HFHC) meal
Subjects will consume a HFHC meal.
HFHC meal includes egg muffin and sausage muffin sandwiches and two hash browns which contain 88g carbohydrates, 51 g fat (33% saturated) and 34 g protein (carbohydrates 41%, protein 17%, and fat 42%).
35 ml of blood will be obtained at 1h ,2h,3h and 4 h and 5 ml at 15 min,30 min,45 min,75 min and 90 min .
A total of 165 ml (11 tablespoon) blood will be collected.
|
900 Cal high fat high carbohydrate fast food meal (HFHC).
meal includes egg muffin and sausage muffin sandwiches and two hash browns which contain 88g carbohydrates, 51 g fat (33% saturated) and 34 g protein (carbohydrates 41%, protein 17%, and fat 42%).
|
Experimental: HFHC meal plus Fiber
HFHC meal includes egg muffin and sausage muffin sandwiches and two hash browns which contain 88g carbohydrates, 51 g fat (33% saturated) and 34 g protein (carbohydrates 41%, protein 17%, and fat 42%).
Subjects will also receive FiberOne Original cereal 14 grams (half cup) before and after the HFHC meal.
35 ml of blood will be obtained at 1h ,2h,3h and 4 h and 5 ml at 15 min,30 min,45 min,75 min and 90 min .
A total of 165 ml (11 tablespoon) blood will be collected.
|
900 Cal high fat high carbohydrate fast food meal containing egg muffin and sausage muffin sandwiches and two hash browns which contain 88g carbohydrates, 51 g fat (33% saturated) and 34 g protein (carbohydrates 41%, protein 17%, and fat 42%).with
FiberOne Original cereal 14 grams (half cup) each before and after the HFHC meal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
effect of addition of fiber on the relative change of NF-Kappa B
Time Frame: Baseline and 1 week
|
The investigators hypothesize that addition of fiber intake will suppress NF-kappa B after HFHC meal.
Therefore, changes in NF-kappa B activity will be compared as percent change form baseline after HFHC meal with or without fiber in lean and obese subjects
|
Baseline and 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
effect of addition of fiber on Changes in ROS generation.
Time Frame: Baseline and 1 week
|
Changes in Reactive oxygen species (ROS) generation between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline.
|
Baseline and 1 week
|
effect of addition of fiber on Changes in TLR-4 mRNA expression in MNC
Time Frame: Baseline and 1 week
|
Changes in TLR-4 mRNA expression in MNC between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline.
|
Baseline and 1 week
|
effect of addition of fiber on Changes in SOCS-3 mRNA expression in MNC
Time Frame: Baseline and 1 week
|
Changes in SOCS-3 mRNA expression in MNC between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline.
|
Baseline and 1 week
|
effect of addition of fiber on Changes in insulin secretion between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline.
Time Frame: Baseline and 1 week
|
Changes in insulin concentrations between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline.
|
Baseline and 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
April 25, 2016
First Submitted That Met QC Criteria
May 19, 2016
First Posted (Estimate)
May 24, 2016
Study Record Updates
Last Update Posted (Estimate)
May 25, 2016
Last Update Submitted That Met QC Criteria
May 23, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1955
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postprandial Inflammation
-
Aarhus University HospitalArla Foods; The Danish Obesity Research Centre; Nordic Centre of ExcellenceCompletedPostprandial Inflammation | Postprandial Lipaemia | Postprandial IncretinsDenmark
-
University of California, DavisCompleted
-
LycoRed Ltd.CompletedPostprandial Oxidation and inflammationIsrael
-
Instituto Tecnológico y de Estudios Superiores...Instituto Tecnológico de TepicRecruitingHyperinsulinism | Hyperglycemia, Postprandial | Markers of InflammationMexico
-
Northumbria UniversityCompletedAppetite | Postprandial Glycaemia, | Postprandial InsulinaemiaUnited Kingdom
-
Aarhus University HospitalThe Danish Obesity Research Centre; Nordic Centre of ExcellenceCompletedInflammation | Obesity | Atherosclerosis | Postprandial Lipemia | Postprandial IncretinsDenmark
-
Solvay PharmaceuticalsCompletedPostprandial Bloating | Postprandial Belching | Postprandial EructationUnited States
-
San Diego State UniversityRecruitingPostprandial Hyperglycemia | Postprandial Glycemic Response | Postprandial InsulinUnited States
-
Hospital de Santo EspíritoEuropean UnionCompleted
-
University of TurkuCompletedPostprandial GlycemiaFinland
Clinical Trials on HFHC meal
-
University of CopenhagenCompletedBiomarkers of Food Intake in Healthy Subjects
-
Ryerson UniversityCompletedObesity | OverweightCanada
-
USDA, Western Human Nutrition Research CenterTerminatedObesity | Overweight | Body WeightUnited States
-
Quadram Institute BioscienceUnilever R&D; Clinical Research and Trials Unit (Norfolk & Norwich University...Completed
-
Clinical Nutrition Research Center, Illinois Institute...CompletedGlycemic ResponseUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
University of Turin, ItalyCompletedChange in Subjective Appetite Score (VAS)Italy
-
Swiss Federal Institute of TechnologyCompleted
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
Swiss Federal Institute of TechnologyUnknownIron-deficiencySwitzerland